Recipient
BioConnect Inc.Department
National Research Council CanadaAmount
$3.0M
Province
ONType
Contribution
Agreement Number
172-2023-2024-Q3-1013396
Purpose
The Build out of the BioConnect Trust Platform is the cloud-architecture with which the Company will transform its operating model from a hardware centric / one-time revenue model to a subscription-based model. The Trust Platform, and its capabilities, will deliver the ongoing value to customers going forward necessary to support a subscription model as demonstrated over last 12 months.
BioConnect Inc. × National Research Council Canada
6 grants totalling $3.1M
Industrial Research Assistance Program – Contributions to Firms
1,000 grants totalling $112.4M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Laurent Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Providence Therapeutics Holdings Inc. | $10.0M | Industrial Research Assistance Program –... |